Back to User profile » Dr Jonas Bergh
Paper published by Dr Jonas Bergh:
Original Research
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling
Wessen Maruwge, Pádraig D’Arcy, Annika Folin, Slavica Brnjic, Johan Wejde, et al
OncoTargets and Therapy 2008, 1:67-78
Published Date: 27 November 2008